soared 21% Thursday after the government issued new guidelines promoting routine HIV testing for most adults.
OraSure makes an HIV test that can detect the presence of antibodies to the virus in 20 minutes, compared with a standard blood test that can take several days, or weeks, for results.
The Centers for Disease Control and Prevention issued guidelines Thursday calling for HIV testing of all patients aged 13 to 64 a part of routine care. The guidelines also promote screening of all pregnant women.
"We are confident that as a result of the revised recommendations, more individuals will get tested and learn their HIV status, and we believe our OraQuick Advance test can serve an important role," said OraSure President and CEO in a statement.
Shares of the Bethlehem, Pa., company recently were up $1.48 to $8.49. More than 14 million shares had changed hands in late afternoon trading, compared with a daily average of roughly 488,000 shares.